NNMT基因多态性与非酒精性脂肪性肝炎的相关性

肖建新; 陈雷

doi:10.3969/j.issn.1001-5256.2013.12.009

NNMT基因多态性与非酒精性脂肪性肝炎的相关性

DOI: 10.3969/j.issn.1001-5256.2013.12.009

肖建新,
陈雷

中国人民解放军第一一八医院消化内科

详细信息

中图分类号: R575.1
计量
- 文章访问数: 2594
- HTML全文浏览量: 13
- PDF下载量: 591
- 被引次数: 0
出版历程
- 收稿日期: 2013-09-03
- 出版日期: 2013-12-20

Association between NNMT gene polymorphism and nonalcoholic steatohepatitis

Department of Gastroenterology, No. 118 Hospital of PLA

摘要

摘要: 目的探讨NNMT基因多态性（rs694539）与非酒精性脂肪性肝炎（NASH）的相关性。方法收集2010年1月至2013年6月本院76例NASH患者和160例与入组患者种族、年龄、性别相匹配的健康志愿者为研究对象,利用聚合酶链限制性长度多态性分析（PCR-RFLP）技术检测NNMT基因多态性。基因型及等位基因频率的比较行χ2检验,两组间均数的比较采用t检验。以非条件性Logistic回归模型计算的比值比及其95%可信区间表示基因型与NASH发生的相对风险度。结果 NNMT基因多态性与NASH发病具有相关性,其中NNMT基因型的GG型（OR为0.57,95%CI为0.330.98;χ2=4.13;P=0.04）为保护因素,AA型（OR为2.55,95%CI为1.105.88;χ2=5.02;P=0.03）为危险因素。NASH患者血清同型半胱氨酸（Hcy）水平显著低于正常对照组[（12.97±1.65）vs（13.52±1.72）μmol/L,P=0.02]。在Logistic回归分析中,将AST、ALT、身体质量指数（BMI）、甘油三酯（TG）...
- 基因多态性 /
- 脂肪肝 /
- 肝炎
Abstract: Objective To investigate the association between nicotinamide N-methyltransferase ( NNMT) gene rs694539 variant and nonalcoholic steatohepatitis ( NASH) . Methods A total of 76 NASH patients who visited or were hospitalized in our hospital from January 2010 to June 2013, as well as 160 healthy volunteers matched with the patients for race, age, and sex, were included in the study. NNMT gene polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism. The genotype and allele frequencies were compared by chi-square test, and comparison of means between two groups was made by t test. The association between NNMT genotypes and NASH was evaluated using odds ratio ( OR) calculated by unconditional logistic regression model, as well as its 95% confidence interval ( CI) . Results NNMT gene rs694539 variant was found to be significantly associated with NASH. GG genotype was a protective factor against NASH ( OR = 0. 57, 95% CI = 0. 33-0. 98; χ2= 4. 13; P = 0. 04) , while AA genotype was a risk factor for NASH ( OR =2. 55, 95% CI = 1. 10-5. 88; χ2= 5. 02; P = 0. 03) . The NASH patients had significantly lower serum homocysteine ( Hcy) levels than the healthy controls ( 12. 97 ± 1. 65 vs 13. 52 ± 1. 72 μmol / L, P = 0. 02) . The logistic regression analysis showed that A allele ( OR = 3. 79, 95% CI = 1. 21-11. 89; P = 0. 02) and alanine aminotransferase ( ALT) ( OR = 1. 08, 95% CI = 1. 05-1. 11; P = 0. 00) were risk factors for NASH after adjustment for sex, aspartate aminotransferase, ALT, body mass index, triglyceride, total cholesterol, and Hcy. Conclusion NNMT gene rs694539 variant is a genetic risk factor for developing NASH.
- gene polymorphism /
- fatty liver /
- hepatitis

HTML全文

参考文献(12)

[1]FARRELL GC, van ROOYEN D, GAN L, et al.NASH is an inflammatory disorder:pathogenic, prognostic and therapeutic implications[J].Gut Liver, 2012, 6 (2) :149-171.

[2]YAO SF, LIU L.Serum homocysteine levels in patients with nonalcoholic fatty liver disease[J].Practical Clin Med, 2012, 13 (4) :11-15. (in Chinese) 姚少芳, 刘琳.非酒精性脂肪肝患者血清同型半胱氨酸水平的研究[J].实用临床医学, 2012, 13 (4) :11-15.

[3]CARR DF, WHITELEY G, ALFIREVIC A, et al.Investigation of inter-individual variability of the one-carbon folate pathway:a bioinformatic and genetic review[J].Pharmacogenomics J, 2009, 9 (5) :291-305.

[4]MALINOWSKA A, CHMURZYNSKA A.Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease[J].Nutr Res, 2009, 29 (10) :685-695.

[5]SOUTO JC, BLANCO-VACA F, SORIA JM, et al.A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels:results from the GAIT project[J].Am J Hum Genet, 2005, 76 (6) :925-933.

[6]Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of nonalcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[7]POLYZOS SA, KOUNTOURAS J, ZAVOS C.Nonalcoholic fatty liver disease:the pathogenetic roles of insulin resistance and adipocytokines[J].Curr Mol Med, 2009, 9 (3) :299-314.

[8]LIU B, WU XL, ZHANG X, et al.Effect of fosinopril on transcription levels of angiotensin-converting enzyme and angiotensin-converting enzyme 2 mRNAs in liver tissues of rats with nonalcoholic steatohepatitis[J].Chin J Biologicals, 2012, 25 (12) :1658-1662. (in Chinese) 刘波, 吴小翎, 张霞, 等.福辛普利对非酒精性脂肪性肝炎大鼠肝组织ACE和ACE2基因mRNA转录水平的影响[J].中国生物制品学杂志, 2012, 25 (12) :1658-1662.

[9]PASCHOS P, PALETAS K.Non alcoholic fatty liver disease and metabolic syndrome[J].Hippokratia, 2009, 13 (1) :9-19.

[10]ZHU CH, CHEN DF, AI ZL, et al.Relationship between serum visfatin and serum adiponectin level and the pathology of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2011, 27 (7) :735-748. (in Chinese) 朱超慧, 陈东风, 艾正琳, 等.血清内脏脂肪素、脂联素与非酒精性脂肪性肝病临床病理的关系[J].临床肝胆病杂志, 2011, 27 (7) :735-748.

[11]SAZCI A, OZEL MD, ERGUL E, et al.Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis[J].Genet Test Mol Biomarkers, 2013.[Epub ahead of print]

[12]ZHANG L, MIYAKI K, ARAKI J, et al.The relation between nicotinamide-N-methyltransferase gen polymorphism and plasma homocysteine concentration in healthy Japanese men[J].Thromb Res, 2007, 121 (1) :55-58.

施引文献

资源附件(0)

访问统计